Ustekinumab Fails to Show Efficacy in a Phase III Axial Spondyloarthritis Program: The Importance of Negative Results.

Document Type

Article

Publication Date

2-1-2019

Publication Title

Arthritis Rheumatol

Clinical Institute

Orthopedics & Sports Medicine

Department

Orthopedics

Department

Rheumatology

Share

COinS